NeuroMab™ Anti-Glypican 3 Antibody, Clone NR21P
A functional antibody raised against Human Glipican3.
- Host Species:
- Human
- Species Reactivity:
- Human
- Applications:
- FC; IHC; Cyt; ADCC; CDC; In Vitro; In Vivo
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
SPECIFIC INQUIRY
inquiryDescription
Immunogen
Species Reactivity
Clonality
Host Species
Clone Number
Applications
Formulation
Preservatives
Concentration
Purification
Purity
Endotoxin Level
Low Endotoxin < 1 EU/mg
Shipping
Storage
Research Use Only
Figure 1 shows the binding affinities of monoclonal antibodies 4A6, 11E7 and 16D10 to the CHC Hep-3B cell line.
Elimination is measured using an antibody-dependent cellular cytotoxicity assay ("ADCC").
Figure 2 shows that monoclonal antibodies 4A6, 11E7 and 16D10 specifically bind to the Hep-G2 cell line. Binding was measured using a FACS assay.
Elimination is measured using an antibody-dependent cellular cytotoxicity assay ("ADCC").
Figure 3 shows that monoclonal antibodies 4A6, 11E7 and 16D10 specifically bind to CHO cells stably transfected with a Glipicano-3 expression vector, but not to CHO progenitor cell lines.
Elimination is measured using an antibody-dependent cellular cytotoxicity assay ("ADCC").
Figure 4 shows the binding of monoclonal antibodies to liver cancer cells taken from patients.
Elimination is measured using an antibody-dependent cellular cytotoxicity assay ("ADCC").
Figure 5 shows that monoclonal antibodies 4A6, 11E7, and 16D10 can mediate natural cytolytic T cell ("NK")-mediated depletion of Hep-3B cells.
Elimination is measured using an antibody-dependent cellular cytotoxicity assay ("ADCC").
Publications (0)
